Cyprotex, a leading provider of in vitro ADME-Tox data, empowers AI drug discovery with high-quality, scalable and cost-effective experimental data. Our flexible, high-throughput workflows support predictive modeling across diverse modalities, enhancing the accuracy and reliability of machine learning (ML) in drug discovery. From ADME profiling and bioanalysis to organ-specific toxicity and advanced cell models, we offer tailored solutions, rapid onboarding, and seamless data integration.
